Drug makers to review complaints on advertisements
Drug makers will set up an office to review complaints about the marketing of prescription drugs, industry officials said as they moved to quiet rising criticism of glitzy commercials and magazine ads.

Chinese generics in US can wreak havoc to Indian drug firms
Indian generic drug firms may have made it big in the United States, but their advantage could fade if China enters the market with its own cheap copies of drugs, India’s top drug maker Ranbaxy said.